Treatment Options for Chronic Venous Insufficiency
The most effective approach to treating chronic venous insufficiency (CVI) begins with compression therapy (20-30 mmHg gradient compression stockings for most patients, 30-40 mmHg for severe disease) as first-line treatment, followed by endovenous thermal ablation procedures for patients with persistent symptoms and documented reflux. 1
Conservative Management
Compression Therapy
- Compression therapy with 20-30 mmHg gradient compression stockings is the cornerstone of CVI treatment 1
- For more severe disease, 30-40 mmHg compression is recommended
- A 3-month trial of compression therapy should be completed before proceeding to interventional treatments
- Common pitfall: Inadequate compression pressure (minimum 20-30 mmHg required) or poor patient compliance 1
Lifestyle Modifications
- Leg elevation to reduce edema and improve symptoms 1
- Weight loss for obese patients 1
- Avoiding prolonged standing and restrictive clothing 1
- Supervised exercise training with leg strength training and aerobic activity for at least 6 months 1
Pharmacological Options
- Phlebotonics (horse chestnut seed extract) for symptomatic relief 1
- Pentoxifylline 400 mg three times daily for ulcer healing (70% more effective than placebo) 1
- Rutosides for symptomatic relief 1
- Oral antihistamines for relief of itching in patients with varicose veins 1
Interventional Treatments
Interventional treatments should be considered when conservative management fails to adequately control symptoms and when specific criteria are met.
Sclerotherapy
- Indicated for spider veins (≤1 mm), reticular veins (1-3 mm), and telangiectasias 1
- Agents include polidocanol (Varithena), sodium tetradecyl (Sotradecol), and hypertonic saline 1
Endovenous Thermal Ablation
- First-line treatment for saphenous vein incompetence 1
- High success rates (91-100% at 1 year) 1
- Indications:
- Vein size >4.5 mm in diameter
- Documented junctional reflux duration ≥500 milliseconds
- Presence of intractable ulceration, hemorrhage, or severe pain and swelling 1
Radiofrequency Ablation
- Recommended for saphenous vein incompetence with vein diameter >4.5mm 1
- High success rates (91-100% at 1 year) with favorable safety profile 1
Surgical Options
- Microphlebectomy/stab phlebectomy for tributary veins exceeding 2.5 mm 1
- Lower recurrence rates compared to sclerotherapy for large varicosities 1
Post-Procedure Care
- Post-procedure compression therapy (20-30 mmHg) to promote vein closure and reduce complications 1
- Walking for 15-20 minutes immediately after the procedure to reduce DVT risk 1
- Follow-up ultrasound to confirm successful vein closure 1
- For venous ulcers: maintain moist environment, provide protective covering, control dermatitis, and aggressively prevent/treat infection 1
Treatment Algorithm
Initial Management (All Patients)
- Compression therapy (20-30 mmHg, or 30-40 mmHg for severe disease)
- Lifestyle modifications (leg elevation, weight loss if applicable, avoiding prolonged standing)
- Consider pharmacological agents for symptom relief
After 3-Month Trial of Conservative Management
- If symptoms persist: Obtain venous duplex ultrasound to assess reflux and vein diameter
- If reflux documented and vein diameter >4.5 mm: Consider endovenous thermal ablation or radiofrequency ablation
- For smaller veins (≤3 mm): Consider sclerotherapy
- For tributary veins >2.5 mm: Consider microphlebectomy
Post-Procedure Management
- Compression therapy
- Regular walking
- Follow-up ultrasound to confirm vein closure
Potential Complications and Pitfalls
- Inadequate compression pressure (minimum 20-30 mmHg required) 1
- Poor patient compliance with compression therapy 1
- Delayed referral for symptomatic patients with documented reflux 1
- Prolonged conservative management without offering interventional treatment when indicated 1
- Failing to obtain venous duplex ultrasound before deciding on treatment approach 1
- Procedure-related complications: phlebitis, new telangiectasias, residual pigmentations, nerve damage (7%), DVT (0.3-0.7%) 1